TY - JOUR T1 - Geographically-targeted COVID-19 vaccination is more equitable and averts more deaths than age-based thresholds alone JF - medRxiv DO - 10.1101/2021.03.25.21254272 SP - 2021.03.25.21254272 AU - Elizabeth Wrigley-Field AU - Mathew V Kiang AU - Alicia R Riley AU - Magali Barbieri AU - Yea-Hung Chen AU - Kate A Duchowny AU - Ellicott C Matthay AU - David Van Riper AU - Kirrthana Jegathesan AU - Kirsten Bibbins-Domingo AU - Jonathon P Leider Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/07/2021.03.25.21254272.abstract N2 - COVID-19 mortality increases dramatically with age and is also substantially higher among Black, Indigenous, and People of Color (BIPOC) populations in the United States. These two facts can have conflicting implications because BIPOC populations are younger than white populations. In analyses of California and Minnesota--demographically divergent states--we show that COVID vaccination schedules based solely on age benefit the older white populations at the expense of younger BIPOC populations with higher risk of death from COVID-19. We find that strategies that prioritize high-risk geographic areas for vaccination at all ages better target mortality risk than age-based strategies alone, although they do not always perform as well as direct prioritization of high-risk racial/ethnic groups. Vaccination schemas directly implicate equitability of access, both domestically and globally.Competing Interest StatementEWF is a member of the Steering Committee of the Seward Vaccine Equity Project, an unpaid volunteer position. All authors declare that they have no competing interests.Funding StatementThis work is supported in part by the National Institutes of Health. EWF, ARR, MB, and DVR are supported in part by the National Institute on Aging (EWF and DVR: P30AG066613; ARR: T32AG049663; MB: P30AG012839 and R03G058110). EWF, DVR, and JPL are supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P2CHD041023). MVK is supported in part by the National Institute on Drug Abuse (K99DA051534). In addition, EWF is supported by a Sustainable Development Goals Rapid Response Grant, a College of Liberal Arts Seed Grant, and during initial data processing stages was supported by the Fesler-Lampert Chair of Aging Studies at the University of Minnesota. This research also relied on data and research support from the National Historical Geographic Information System (NHGIS), which is supported by the National Institutes of Health (R01HD057929) and National Science Foundation (1825768). Finally, we thank the Berkeley Workshop in Formal Demography (supported by the National Institutes of Health [R25HD083136, P30AG012839, P2CHD073964]), which facilitated the initial connection between the California-based and Minnesota-based research teams. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was deemed exempt from full review by the University of Minnesota institutional review board (STUDY00012527) and was approved by the California Health and Human Services institutional review board (Project number: 2020-109).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. The data can be downloaded from a permanent repository at https://osf.io/tzeq3/?view_only=191ff8cfbd104e3aa2e76518af554943 ER -